Development and evaluation of a colorimetric PCR system for the detection and typing of human papillomaviruses

International Journal of Molecular Medicine

Volumn 18, Issue 5, 2006, Pages 995-1003

  Chouhy, Diego ^a,b   Gil, Lisandro Benítez ^c   Nocito, Ana L ^a   Wojdyla, Daniel ^a   Ornella, Leonardo ^a   Cittadini, Jorge ^c   Gardiol, Daniela ^a,b   Giri, Adriana A ^a,b  

^a UNIVERSIDAD NACIONAL DE ROSARIO   (Argentina)

^b Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

^c Hospital Provincial del Centenario   (Argentina)

Author keywords

Argentina; Cervical cancer; Developing countries; HPV DNA testing; PCR EIA assay

Indexed keywords

PRIMER DNA; VIRUS DNA;

ADOLESCENT; ADULT; AGED; ARTICLE; CLASSIFICATION; COLORIMETRY; DNA PROBE; EVALUATION; FEMALE; GENETICS; HUMAN; ISOLATION AND PURIFICATION; METHODOLOGY; MIDDLE AGED; PAPILLOMA VIRUS; POLYMERASE CHAIN REACTION; UTERINE CERVIX TUMOR; VIROLOGY; VIRUS INFECTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; COLORIMETRY; DNA PRIMERS; DNA PROBES, HPV; DNA, VIRAL; FEMALE; HUMANS; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; UTERINE CERVICAL NEOPLASMS;

EID: 36349032953     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.18.5.995     Document Type: Article

References (39)

1. World Health Organization: Cervical cancer screening in developing countries: report of a WHO consultation. World Health Organization, Geneva (ISBN 9241545720), 2002.
2. Ferlay J, Bray F, Pisani P and Parkin DM: Globocan 2000: cancer incidence, mortality and prevalence worldwide, version 1.0. IARC CancerBase no. 5. IARC Press, Lyons, 2001.
3. Lewis MJ: A situational analysis of cervical cancer in Latin America and the Caribbean. Washington, DC, PAHO:2004, 2004.
4. Solomon D, Davey D, Kurman R, et al: The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA 287: 2114-2119, 2002.
5. Coutlée F, Mayrand MH, Provencher D and Franco E: The future of HPV testing in clinical laboratories and applied virology research. Clin Diagn Virol 8: 123-141, 1997.
6. Cuzick J, Meijer CJ and Walboomers JM: Screening for cervical cancer. Lancet 351: 1439-1440, 1998.
7. Cuzick J: Role of HPV testing in clinical practice. Virus Res 89: 263-269, 2002.
8. Zur Hausen H: Papillomavirus infections - a major cause of human cancer. Biochim Biophys Acta 1288: F55-F78, 1996.
9. Zur Hausen H: Papillomavirus in human cancers. Proc Assoc Am Physicians 6: 581-587, 1999.
10. Muñoz N, Bosch FX, Sanjosé S, et al: Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348: 518-527, 2003. (Pubitemid 36159887)
11. Walboomers JMM, Jacobs MV, Manos MM, et al: Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189: 12-19, 1999.
12. Lorincz AT and Richart RM: Human papillomavirus ADN testing as an adjunct to cytology in cervical screening programs. Arch Pathol Lab Med 127: 959-968, 2003.
13. Manos MM, Ting Y, Wright DK, Lewis AJ, Broker T and Wolinski SM: Use of polymerase chain reaction amplification for the detection of genital human papillomaviruses. Cancer Cells 7: 209-214, 1989.
14. Bosch FX, Manos MM, Muñoz N, et al: Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. J Natl Cancer Inst 87: 796-802, 1995.
15. Nobbenhuis MA, Walboomers JMM, Helmerhorst TJ, et al: Relation of human papillomavirus status to cervical lesions and consequences for cervical cancer screening: a prospective study. Lancet 354: 20-25, 1999.
16. Ting Y and Manos MM: Detection and typing of genital human papillomaviruses. In: PCR Protocols: A Guide to Methods and Applications. Innis MA, Gelfand DH, Sninsky JJ and White TJ (eds). Academic Press, San Diego, pp356-367, 1990.
17. Syrjänen K and Syrjänen S: Papillomavirus Infections in Human Pathology. John Wiley & Sons, Inc., New York, NY, 2000.
18. Jones HW Jr, McKusick VA, Harpe PS and Wuu K-D: The HeLa cell and a reappraisal of its origin. Obstet Gynecol 38: 945-959, 1971.
19. Pattillo RA, Hussa RO, Story MT, Ruckert ACF, Shalaby MR and Mattingly RF: Tumor antigen and human chorionic gonadotropin in CaSki cells: a new epidermoid cervical cancer cell line. Science 196: 1456-1458, 1977.
20. Grce M, Husnjak K, Bozikov J, et al: Evaluation of genital human papillomavirus infections by polymerase chain reaction among Croatian women. Anticancer Res 21B: 579-584, 2001.
21. Wright DK and Manos MM: Sample preparation from paraffin-embedded tissues. In: PCR Protocols: A Guide to Methods and Applications. Innis MA, Gelfand DH, Sninsky JJ and White TJ (eds). Academic Press, San Diego, pp153-156, 1990.
22. Saiki RK, Bugawan TL, Horn GR, Mullis KB and Erlich HA: Analysis of enzymatically amplified β-globin and HLA DNA with allele-specific oligonucleotide probes. Nature 324: 163-166, 1986.
23. Fleiss JL: Statistical Methods for Rates and Proportions. 2nd edition. John Wiley, New York, pp211-232, 1981.
24. Agresti A: Categorical Data Analysis. 2nd edition. John Wiley & Sons, Inc., Hoboken, New Jersey, pp165-195, 2002.
25. Efron B and Tibshirani R: An Introduction to the Bootstrap. Chapman & Hall, New York, 1993.
26. McDermott JL, Giri AA, Martini I, et al: HIV DNA in peripheral blood mononuclear cells correlates with antiretroviral therapy efficacy. J Clin Microbiol 37: 2361-2365, 1999.
27. Gariglio R, Taborda MA, Bortolozzi R, et al: Non-conventional virological markers in HIV-infected patients: T-HIV DNA, 2LTR-HIV DNA and HIV RNA. Medicina 64: 419-428, 2004.
28. Bosch FX, Lorincz A, Muñoz N, Meijer CJ and Shah KV: The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 55: 244-265, 2002. (Pubitemid 34293391)
29. Jacobs MV, Snijders PJF, van Den Brule AJC, Helmerhorst TJM, Meijer CJLM and Walboomers JMM: A general primer GP51/GP61-mediated PCR-enzyme immunoassay method for rapid detection of 14 high-risk and 6 low-risk human papillomavirus genotypes in cervical scrapings J Clin Microbiol 35: 791-795, 1997.
30. Hart KW, Williams OM, Thelwell N, Fiander AN, Brown T, Borysiewicz LK and Gelder CM: Novel method for detection, typing, and quantification of human papillomaviruses in clinical samples. J Clin Microbiol 39: 3204-3212, 2001.
31. Swan DC, Tucker RA, Tortolero-Luna G, et al: Human papillomavirus (HPV) DNA copy number is dependent on grade of cervical disease and HPV type. J Clin Microbiol 37: 1030-1034, 1999.
32. Schiffman MH, Kiviat NB, Burk RD, et al: Accuracy and interlaboratory reliability of human papillomavirus DNA testing by hybrid capture. J Clin Microbiol 33: 545-550, 1995.
33. Cullen AP, Reid R, Campion M and Lorincz A: Analysis of the physical state of different human papillomavirus DNAs in intraepithelial and invasive cervical neoplasm. J Virol 65: 606-612, 1991.
34. Matos E, Loria D, Amestoy GM, et al: Prevalence of human papillomavirus infection among women in Concordia, Argentina: a population-based study. Sex Transm Dis 30: 593-599, 2003.
35. Abba MC, Gomez MA and Golijow CD: Human papillomavirus genotype distribution in cervical infections among woman in La Plata, Argentina. Rev Argent Microbiol 35: 74-79, 2003.
36. Tonon SA, Picconi MA, Zinovich JB, et al: Human papillomavirus cervical infection and associated risk factors in a region of Argentina with a high incidence of cervical carcinoma. Infect Dis Obstet Gynecol 7: 237-243, 1999.
37. Deluca GD, Lucero RH, De Civetta M, Vicente L, De Gorodner OLZ, Schelover E and Alonso JM: Human papillomavirus genotypes in women with cervical cytological abnormalities from an area with high incidence of cervical cancer. Rev Inst Med Trop S Paulo 46: 9-12, 2004.
38. Ho GYF, Bierman R, Beardsley L, Chang CJ and Burk RD: Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 338: 423-429, 1998.
39. Koutsky LA, Holmes KK, Critchlow CW, et al: A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N Engl J Med 327: 1272-1278, 1992.